China · Investor

Sinopharm Capital

Last cheque observed Aug 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equity

Series BBiotechnologySex TechHealth Care

Cheques on record
0%of best year0cheques in 12 months, 2 on record
Since the last cheque2632days00hrs00min00sec
Median round$14MRounds led0 of 2Sole investor1 rounds
Pitch Sinopharm Capital

Sinopharm Capital highlights

  1. 01

    2 rounds on record

  2. 02

    Mostly Series B: 100% of its rounds

  3. 03

    Sole investor in 1 rounds, median $9.3M

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Sectors
BiotechnologySex TechHealth Care
Based in
China
Cold pitches
Not stated

The record

Every round we can evidence, newest first2 appearances

  1. 2019

    1 round

  2. Aug
    BaicareSeries B · CN · Sohu$9.3MSole investor
  3. 2017

    1 round

  4. Dec
    Virtual IncisionSeries B · CA · FinSMEs$18MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 2 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Quick answers about Sinopharm Capital

What does Sinopharm Capital invest in?

Sinopharm Capital invests most often at Series B (100% of the rounds on record), in sectors such as Biotechnology, Sex Tech and Health Care.

How active is Sinopharm Capital?

2 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2019.

What has Sinopharm Capital invested in recently?

Its most recent investments on record: Baicare (Series B, Aug 2019) and Virtual Incision (Series B, Dec 2017).

How big are Sinopharm Capital's cheques?

The median round it joins is $14M.

Is Sinopharm Capital investing now?

No investments in the last 12 months; the latest was in Aug 2019.

What kind of investor is Sinopharm Capital?

Sinopharm Capital is a growth equity firm based in China.

When was Sinopharm Capital founded?

Sinopharm Capital was founded in 2012.

Where does this information on Sinopharm Capital come from?

From 2 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it